|
|
News Breaks | | | | December 10, 2012 | | 13:20 EDT |  | MAKO | MAKO Surgical weakness a buying opportunity, says Piper Jaffray
Piper Jaffray views the weakness in shares of MAKO Surgical after Blue Belt's NavioPFS orthopedic surgery system received FDA approval as a buying opportunity. Piper thinks it will take time for NavioPFS to build momentum, but adds the approval means competition for MAKO in the U.S. The firm recommends buying shares on MAKO on today's weakness and reiterates an Overweight rating on the stock. | |
|
News For MAKO From The Last 14 Days Check below for free stories on MAKO the last two weeks. |
|
|
| June 14, 2013 | | 06:47 EDT | | MAKO | MAKO data validates knee, hip applications, says Piper Jaffray
 Subscribe for More Information | |
|
|
|
|
|
|
